Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Lipid Insights | journal | 1.500 Q1 | 17 | 1 | 18 | 10 | 79 | 16 | 6.60 | 10.00 | |
2 | International Journal of Tryptophan Research | journal | 1.546 Q1 | 33 | 6 | 24 | 577 | 112 | 24 | 5.88 | 96.17 | |
3 | Journal of Cell Death | journal | 1.333 Q1 | 19 | 4 | 10 | 194 | 50 | 10 | 5.13 | 48.50 | |
4 | International Journal of Nanomedicine | journal | 1.098 Q1 | 179 | 605 | 1696 | 30652 | 8610 | 1683 | 4.74 | 50.66 | |
5 | Nanotheranostics | journal | 32 | 32 | 32 | 1822 | 134 | 32 | 4.19 | 56.94 | ||
6 | International Journal of Biological Sciences | journal | 1.309 Q2 | 118 | 195 | 411 | 10809 | 1736 | 407 | 4.14 | 55.43 | |
7 | Application of Clinical Genetics | journal | 2.745 Q1 | 40 | 22 | 58 | 718 | 320 | 57 | 4.06 | 32.64 | |
8 | Advances and Applications in Bioinformatics and Chemistry | journal | 1.386 Q1 | 19 | 1 | 13 | 23 | 74 | 13 | 3.75 | 23.00 | |
9 | Journal of Experimental Pharmacology | journal | 0.937 Q2 | 23 | 9 | 21 | 630 | 72 | 21 | 3.35 | 70.00 | |
10 | Pharmacogenomics and Personalized Medicine | journal | 0.965 Q2 | 37 | 23 | 61 | 1180 | 199 | 58 | 3.22 | 51.30 | |
11 | Breast Cancer: Basic and Clinical Research | journal | 0.951 Q3 | 35 | 19 | 67 | 711 | 189 | 67 | 3.00 | 37.42 | |
12 | Genetics and Epigenetics | journal | 0.879 Q2 | 12 | 0 | 16 | 0 | 45 | 16 | 2.92 | 0.00 | |
13 | Stem Cells and Cloning: Advances and Applications | journal | 1.248 Q2 | 27 | 10 | 19 | 561 | 107 | 19 | 2.60 | 56.10 | |
14 | Clinical Biochemist Reviews | journal | 0.470 Q3 | 36 | 8 | 20 | 518 | 44 | 16 | 2.54 | 64.75 | |
15 | Evolutionary Bioinformatics | journal | 0.932 Q2 | 38 | 33 | 109 | 1486 | 266 | 107 | 2.14 | 45.03 | |
16 | Biomarker Insights | journal | 0.758 Q3 | 40 | 24 | 117 | 1491 | 247 | 116 | 1.98 | 62.13 | |
17 | Analytical Chemistry Insights | journal | 0.486 Q3 | 22 | 5 | 27 | 289 | 45 | 27 | 1.94 | 57.80 | |
18 | Gene Regulation and Systems Biology | journal | 0.686 Q3 | 22 | 1 | 28 | 36 | 55 | 28 | 1.80 | 36.00 | |
19 | Reproduction, Fertility and Development | journal | 0.716 Q2 | 84 | 164 | 539 | 9596 | 1042 | 535 | 1.76 | 58.51 | |
20 | Translational Oncogenomics | journal | 1.469 Q2 | 11 | 0 | 8 | 0 | 32 | 8 | 1.67 | 0.00 | |
21 | Bioinformatics and Biology Insights | journal | 0.705 Q3 | 32 | 8 | 89 | 569 | 206 | 86 | 1.57 | 71.13 | |
22 | Proteomics Insights | journal | 0.337 Q4 | 7 | 0 | 5 | 0 | 7 | 5 | 1.40 | 0.00 | |
23 | Cancer Informatics | journal | 0.711 Q3 | 37 | 20 | 145 | 634 | 207 | 142 | 1.32 | 31.70 | |
24 | Journal of Receptor, Ligand and Channel Research | journal | 0.203 Q4 | 13 | 2 | 6 | 231 | 4 | 6 | 1.00 | 115.50 | |
25 | Fluoride - Quarterly Reports | journal | 0.323 Q4 | 51 | 32 | 132 | 1198 | 142 | 119 | 0.98 | 37.44 | |
26 | Genomics Insights | journal | 0.266 Q4 | 10 | 3 | 8 | 63 | 7 | 8 | 0.86 | 21.00 | |
27 | Cell Health and Cytoskeleton | journal | 0.765 Q2 | 16 | 0 | 17 | 0 | 27 | 17 | 0.50 | 0.00 | |
28 | Cancer Forum | journal | 0.181 Q4 | 15 | 9 | 113 | 385 | 37 | 103 | 0.41 | 42.78 | |
29 | International Journal of Bio-Science and Bio-Technology (discontinued) | journal | 0.120 Q4 | 22 | 0 | 357 | 0 | 114 | 352 | 0.31 | 0.00 | |
30 | Journal of Commercial Biotechnology | journal | 0.156 Q4 | 19 | 27 | 99 | 515 | 30 | 98 | 0.18 | 19.07 | |
31 | New Zealand Journal of Medical Laboratory Science | journal | 0.186 Q4 | 9 | 17 | 45 | 339 | 9 | 32 | 0.15 | 19.94 | |
32 | Australasian Biotechnology | journal | 0.101 Q4 | 9 | 0 | 97 | 0 | 1 | 67 | 0.02 | 0.00 | |
33 | Australian Journal of Medical Science | journal | 0.128 Q4 | 6 | 0 | 11 | 0 | 1 | 11 | 0.00 | 0.00 | |
34 | Blood and Lymphatic Cancer: Targets and Therapy | journal | 0.124 Q4 | 1 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®